FDA Approved: AMPHETAMINE EXTENDED-RELEASE — Original Application (Neos Therapeutics, LP)

View source ↗

Summary

FDA approved AMPHETAMINE EXTENDED-RELEASE under an original NDA for the treatment of attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• AMPHETAMINE EXTENDED-RELEASE (Amphetamine extended-release)

Snippet

ORIG AP for AMPHETAMINE EXTENDED-RELEASE (AMPHETAMINE EXTENDED-RELEASE)